Rockwell Medical, Inc. (NASDAQ:RMTI) headquartered in Wixom, will host a conference call for the investment community to discuss the 2Q20 earnings result on 10th August 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.rockwellmed.com
Earnings Expectation
Rockwell Medical, Inc. is reporting second quarter earnings results on Monday 10th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.14 per share. For the full year, analysts predict revenues of $ 68.11 million, while looking forward to loss of $ 0.51 per share.
Rockwell Medical, Inc. operates as a specialty pharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
